Status:
COMPLETED
Risk of Asthma in Infants With Atopic Dermatitis
Lead Sponsor:
Indiana University School of Medicine
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Asthma
Eczema
Eligibility:
All Genders
2-7 years
Brief Summary
Infants will be enrolled in this study if they have never been diagnosed with asthma or wheezing and have been diagnosed with atopic dermatitis or eczema. Infants with some types of skin rashes are at...
Detailed Description
Asthma is a disease characterized by recurrent episodes of wheezing, inflammation of the airways, and airways that are very sensitive to stimulation (hyper-responsiveness). Symptoms of asthma frequent...
Eligibility Criteria
Inclusion
- Inclusion criteria-
- Full term infants born greater than 37 weeks
- History of atopic dermatitis or eczema
- Exclusion criteria
- Heart disease
- asthma
- Respiratory illness such as RSV, bronchiolitis or croup
- Hospitalization for respiratory illness
- History of wheezing
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00459576
Start Date
May 1 2005
End Date
December 1 2012
Last Update
April 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riley Hospital for Children
Indianapolis, Indiana, United States, 46202